GRI Bio Conditionally Regains Nasdaq Compliance, Averting Immediate Delisting

summarizeSummary

GRI Bio, Inc. has been notified by Nasdaq that it has conditionally regained compliance with the $2.5 million stockholders' equity requirement, removing the immediate threat of delisting.

check_boxKey Events

• Conditional Compliance Regained

  GRI Bio, Inc. received notification from Nasdaq that it has conditionally regained compliance with the $2.5 million stockholders' equity requirement (Nasdaq Listing Rule 5550(b)(1)).

• Delisting Threat Averted

  This notification removes the immediate threat of delisting from The Nasdaq Capital Market, which was previously reported on December 2, 2025.

• Ongoing Monitoring Required

  The company must continue to demonstrate compliance in future Exchange Act reports, or its common stock may again be subject to delisting.

auto_awesomeAnalysis

This 8-K reports a significant positive development for GRI Bio, Inc., as it has conditionally satisfied Nasdaq's $2.5 million stockholders' equity requirement. This action removes the immediate risk of delisting from The Nasdaq Capital Market, which was previously disclosed. While this provides a reprieve, the compliance is conditional, and the company must continue to demonstrate adherence to the listing rules in future financial reports to avoid renewed delisting proceedings. Investors should monitor the company's financial performance closely to ensure sustained compliance.